Back to Editor profile » Professor Shein-Chung Chow

Professor Shein-Chung Chow

Professor Shein-Chung Chow

Associate Editor: Professor Shein-Chung Chow

Dr. Chow is currently a professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.  Prior to joining Duke University, he held various positions including the Director of TCOG (Taiwan Cooperative Oncology Group) Statistical Center and the Executive Director of National Clinical Trial Network Coordination Center, Taiwan; Vice President, Biostatistics, Data Management, and Medical Writing at Millennium Pharmaceuticals, Inc., Cambridge, MA, USA; Executive Director, Statistics and Clinical Programming at Covance, Inc., and Director and Department Head at Bristol-Myers Squibb Company, Plainsboro, NJ, USA. Through these positions, Dr. Chow provides technical supervision and guidance to project teams on statistical issues and presentations before partners, regulatory agencies or scientific bodies, defending the appropriateness of statistical methods used in clinical trial design or data analyses or the validity of reported statistical inferences. Dr. Chow identifies the best statistical and data management practices, organizes and leads working parties for development of statistical design, analyses and presentation applications, and participated on Data Safety Monitoring Boards in clinical research and development.

Dr. Chow's professional activities include playing key roles in many professional organizations such as officer, board of directors member, advisory committee member, and executive committee member. He has served as program-chair, session-chair/moderator, panelist and instructor/faculty at many professional conferences, symposia, workshops, tutorials and short courses. He is also the Editor-in-Chief of the Journal of Biopharmaceutical Statistics, Drug Designing – Open Access, and of the Biostatistics Book Series at Chapman and Hall/CRC Press of Taylor & Francis Group. He was elected Fellow of the American Statistical Association and an elected member of the ISI (International Statistical Institute). Most recently, representing academic and scientific experts, Dr. Chow was invited to speak at US FDA Public Hearings on Approval Pathway for Biosimilar and Interchangeable Biological Products (November 2-3, 2010) and Draft Guidances Relating to the Development of Biosimilar Products (May 11, 2012). 

Dr. Chow is the author or co-author of over 250 methodology papers and 24 books, which include Advanced Linear Models, Design and Analysis of Bioavailability and Bioequivalence Studies (1st, 2nd, and 3rd editions), Statistical Design and Analysis in Pharmaceutical Science, Design and Analysis of Clinical Trials (1st and 2nd editions), Design and Analysis of Animal Studies in Pharmaceutical Development, Encyclopedia of Biopharmaceutical Statistics (1st, 2nd, and 3rd editions), Sample Size Calculations in Clinical Research, Adaptive Design Methods in Clinical Trials, Statistical Design and Analysis of Stability Studies, Translational Medicine,  Handbook for Adaptive Design in Pharmaceutical Research and Development, Controversial Statistical Issues in Clinical Trials, Design and Analysis of Bridging Studies, and BIOSIMILARS: Design and Analysis of Follow-on Biologics, and Quantitative Methods for Traditional Chinese Medicine Development. Dr. Chow is currently working on two books: one is for Biosimilar Drug Development and the other one related to HIV/AIDS Research.

Dr. Chow received a BS in mathematics from National Taiwan University, Taiwan, and a PhD in statistics from the University of Wisconsin, Madison, Wisconsin, USA.